Named patient access
We help authorised healthcare teams structure named-patient access enquiries and research potential licensed pathways for medicines not routinely available in their market.
Professional access coordination
Riverpharma helps healthcare organisations, medicine developers, authorisation holders, sponsors and research teams structure specialist medicine access and regulatory enquiries. We coordinate defined workstreams with responsible organisations and support specialist logistics handovers when a viable pathway moves forward.
For professional organisations only · No patient orders or prescriptions
Specialist pathways
Every enquiry begins with scope, evidence and the legal pathway—not a stock list or an availability promise.
We help authorised healthcare teams structure named-patient access enquiries and research potential licensed pathways for medicines not routinely available in their market.
We support sponsors, CROs and research sites with comparator and reference-product enquiry scoping, documentation coordination and referrals to authorised supply partners.
We research potential access routes and coordinate professional introductions for rare-disease and complex medicine enquiries where standard channels are not enough.
We help medicine developers, manufacturers and marketing authorisation holders structure UK and EU regulatory workstreams, from pathway and dossier-readiness planning to submission coordination, variations and lifecycle milestones.
Supporting capability
Access-pathway work remains our core service. As a secondary capability, Riverpharma can coordinate the operational handover between the requesting organisation and separately contracted, appropriately authorised supply and logistics providers.
Explore logistics coordination →Riverpharma does not act as carrier, wholesaler, importer or exporter and does not transport, store or physically handle medicines.
The Riverpharma role
Hard-to-source medicine enquiries often involve more than finding a name on a list.
Market availability, product identity, intended use, import rules, clinical responsibility and authorised supply all need to align. Riverpharma brings structure to that early-stage work.
We do not replace the prescriber, sponsor, regulator, importer or licensed supplier. We help the right professional organisations reach the right questions—and, where appropriate, the right authorised parties.
Read our operating boundary ↓A disciplined process
We establish the exact medicine, presentation, intended market, organisation type, timeframe and access context.
We research potential routes, identify the questions that must be resolved and set out what evidence may be needed.
Where a viable route exists, we coordinate introductions to appropriately authorised organisations for their own assessment.
Roles, documents and next actions are made explicit so regulated decisions remain with the responsible parties.
Prepare an enquiry
Share enough to define the professional requirement, but do not send patient-identifiable information, prescriptions or medical records in an initial enquiry.
Prepare your enquiry →Brand or ingredient, strength, dosage form, pack details and manufacturer where known.
Named-patient, clinical-trial, comparator, marketing-authorisation or another professional requirement.
Target country or market, required timeframe, current authorisation status and any known regulatory considerations.
Your professional role, organisation type and a business email address.
Operating boundary
Riverpharma Ltd does not hold a WDA(H). Any regulated procurement, importation, carriage, storage, distribution or supply is undertaken directly by separately contracted, appropriately authorised organisations after their own assessment and required approvals.
Professional enquiries
Use the secure form to send a structured professional enquiry into Riverpharma's private operations workspace. You will receive a reference immediately; direct email remains available if you prefer it.
Company information